Is the FDA killing innovation?
Investors say the FDA's approval process of medical devices is inefficient and opaque. The maker of a non-invasive device that's proven to identify melanomas risks it all to tell the tale.

All Approvals Are Not Created Equal
MELA's EU approval isn't nearly as important as one stateside.